pemetrexed,cisplatin,gemcitabine,pembrolizumab
merck
['keytruda', 'merck']
breaking news: #mrk healthcare giant merck &amp; company, inc. is seeing a spike in their stock price due to a study reporting that keytruda cuts the risk of recurrence, progression or death by 42%. get in on the action now at $112.7! #asco23 #investing #stock 
Mathematician running a quant fund. Real-time performance updates and stock alerts from your favourite financial gurus  🦧